These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
108 related articles for article (PubMed ID: 3008529)
1. Determinants of inflammation test selection: in vitro or in vivo? Parnham MJ Agents Actions; 1986 Jan; 17(3-4):327-8. PubMed ID: 3008529 [No Abstract] [Full Text] [Related]
2. Benoxaprofen does not inhibit formation of leukotriene B4 in a model of acute inflammation. Salmon JA; Tilling LC; Moncada S Biochem Pharmacol; 1984 Sep; 33(18):2928-30. PubMed ID: 6089840 [No Abstract] [Full Text] [Related]
3. The hallucinogenic diterpene salvinorin A inhibits leukotriene synthesis in experimental models of inflammation. Rossi A; Pace S; Tedesco F; Pagano E; Guerra G; Troisi F; Werner M; Roviezzo F; Zjawiony JK; Werz O; Izzo AA; Capasso R Pharmacol Res; 2016 Apr; 106():64-71. PubMed ID: 26859523 [TBL] [Abstract][Full Text] [Related]
4. [Recent discoveries in the field of mediators of anti-inflammation: leukotrienes]. Fantini F Clin Ter; 1984 May; 109(4):355-61. PubMed ID: 6088163 [No Abstract] [Full Text] [Related]
5. Prostaglandins, thromboxanes, and leukotrienes in inflammation. Malmsten CL Am J Med; 1986 Apr; 80(4B):11-7. PubMed ID: 2871754 [TBL] [Abstract][Full Text] [Related]
6. Modulation of inflammatory disease by inhibitors of leukotriene A4 hydrolase. Fourie AM Curr Opin Investig Drugs; 2009 Nov; 10(11):1173-82. PubMed ID: 19876785 [TBL] [Abstract][Full Text] [Related]
7. Inflammation and insulin resistance: New targets encourage new thinking: Galectin-3 and LTB Johnson AMF; Hou S; Li P Bioessays; 2017 Sep; 39(9):. PubMed ID: 28752547 [TBL] [Abstract][Full Text] [Related]
9. Novobiocin, an antagonist of leukotriene B4. Tsujii E; Shigematsu N; Hatanaka H; Yamashita M; Okamoto M; Okuhara M J Antibiot (Tokyo); 1992 Dec; 45(12):1958-60. PubMed ID: 1337065 [No Abstract] [Full Text] [Related]
10. The anti-inflammatory effect of montelukast, a cysteinyl leukotriene receptor-1 antagonist, against estradiol-induced nonbacterial inflammation in the rat prostate. Said MM; Bosland MC Naunyn Schmiedebergs Arch Pharmacol; 2017 Feb; 390(2):197-205. PubMed ID: 27909742 [TBL] [Abstract][Full Text] [Related]
11. [Pharmacology of leukotrienes]. Zhang HQ Sheng Li Ke Xue Jin Zhan; 1984 Oct; 15(4):333-6. PubMed ID: 6100533 [No Abstract] [Full Text] [Related]
12. The cellular effects of nonsteroidal anti-inflammatory drugs cannot be due to inhibition of prostaglandin release. Weissmann G; Rich AM; Anderson C; Haines KA; Korchak HM; Dunham P Trans Assoc Am Physicians; 1984; 97():369-83. PubMed ID: 6100152 [No Abstract] [Full Text] [Related]
13. [Current aspects of the inflammation phenomenon and mechanism of action of anti-inflammatory agents]. Dreux C Sem Hop; 1983 Dec; 59(46):3173-6. PubMed ID: 6318333 [No Abstract] [Full Text] [Related]
14. Human peritoneal macrophages: clinical models of inflammation and potential targets of antiinflammatory drugs. Wilson JH; Bonta IL Agents Actions; 1986 Jan; 17(3-4):338-41. PubMed ID: 3083658 [TBL] [Abstract][Full Text] [Related]
15. In vitro and in vivo pharmacological characterization of BIIL 284, a novel and potent leukotriene B(4) receptor antagonist. Birke FW; Meade CJ; Anderskewitz R; Speck GA; Jennewein HM J Pharmacol Exp Ther; 2001 Apr; 297(1):458-66. PubMed ID: 11259574 [TBL] [Abstract][Full Text] [Related]
16. The regulation of CD11b integrin levels on human blood leukocytes and leukotriene B4-stimulated skin by a specific leukotriene B4 receptor antagonist (LY293111). van Pelt JP; de Jong EM; van Erp PE; Mitchell MI; Marder P; Spaethe SM; van Hooijdonk CA; Kuijpers AL; van de Kerkhof PC Biochem Pharmacol; 1997 Apr; 53(7):1005-12. PubMed ID: 9174114 [TBL] [Abstract][Full Text] [Related]
17. Prostaglandins and leukotrienes in inflammation and allergy. Van de Stadt KD Neth J Med; 1982; 25(1):22-9. PubMed ID: 6276800 [No Abstract] [Full Text] [Related]
18. Selective inhibition of leukotriene B4 formation by Ebselen: a novel approach to antiinflammatory therapy. Kuhl P; Borbe HO; Römer A; Fischer H; Parnham MJ Agents Actions; 1986 Jan; 17(3-4):366-7. PubMed ID: 3008531 [No Abstract] [Full Text] [Related]
19. Flavonoid-enriched fraction from Echinodorus macrophyllus aqueous extract exhibits high in-vitro and in-vivo anti-inflammatory activity. da Silva GP; Fernandes DC; Vigliano MV; da Fonseca EN; Santos SV; Marques PR; Justo MD; Sabino KC; Coelho MG J Pharm Pharmacol; 2016 Dec; 68(12):1584-1596. PubMed ID: 27726146 [TBL] [Abstract][Full Text] [Related]
20. Huang-Lian-Jie-Du-Tang exerts anti-inflammatory effects in rats through inhibition of nitric oxide production and eicosanoid biosynthesis via the lipoxygenase pathway. Zeng H; Liu X; Dou S; Xu W; Li N; Liu X; Zhang W; Hu Z; Liu R J Pharm Pharmacol; 2009 Dec; 61(12):1699-707. PubMed ID: 19958594 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]